These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7539177)

  • 21. A urodynamic review of bladder outlet obstruction in the male and its clinical implications.
    Warwick RT
    Urol Clin North Am; 1979 Feb; 6(1):171-92. PubMed ID: 86223
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical significance of residual urine volume in bladder outlet obstruction with benign prostatic hyperplasia].
    Wu Z; Wu K; Wang B
    Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):374-6. PubMed ID: 10374477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction.
    Sullivan MP; Yalla SV
    J Urol; 1996 Jun; 155(6):1995-2000. PubMed ID: 8618307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of MR imaging and urodynamic findings in benign prostatic hyperplasia.
    Alam AM; Sugimura K; Okizuka H; Ishida J; Igawa M
    Radiat Med; 2000; 18(2):123-8. PubMed ID: 10888045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bladder instability in patients with prostatic hypertrophy. Urodynamic study].
    Aragona F; Marconi A; Spinelli C; Morelli G; Murzi P
    Ann Urol (Paris); 1987; 21(1):13-6. PubMed ID: 2436567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine bladder biopsies in men with bladder outlet obstruction?
    Horn T; Kortmann BB; Holm NR; Smedts F; Nordling J; Kiemeney LA; de la Rosette JJ
    Urology; 2004 Mar; 63(3):451-6. PubMed ID: 15028436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction.
    Groutz A; Blaivas JG; Fait G; Sassone AM; Chaikin DC; Gordon D
    J Urol; 2000 Jan; 163(1):207-11. PubMed ID: 10604349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy.
    Javlé P; Jenkins SA; West C; Parsons KF
    J Urol; 1996 Sep; 156(3):1014-8; discussion 1018-9. PubMed ID: 8709299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of infravesical obstruction in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Amdiĭ RE
    Urologiia; 2006; (2):41-3, 45. PubMed ID: 16708588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urodynamic studies on benign prostatic hyperplasia combined with diabetes mellitus].
    Ding J; Qi L; Zu X; Shen P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 35(7):705-10. PubMed ID: 20693712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic scale of infravesical obstruction in patients d with benign prostatic hyperplasia].
    Aboian IA; Golovko SIu; Khitar'ian AG; Levin EG; Pavlov SV
    Urol Nefrol (Mosk); 1998; (6):32-7. PubMed ID: 10051826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral Tadenan treatment on rabbit bladder structure and function after partial outlet obstruction.
    Levin RM; Hass MA; Bellamy F; Horan P; Whitbeck K; Chow PH; Kung LS; Gosling J
    J Urol; 2002 May; 167(5):2253-9. PubMed ID: 11956488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uroflowmetry and evaluation of voiding disorders.
    Ather MH; Memon A
    Tech Urol; 1998 Sep; 4(3):111-7. PubMed ID: 9800886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and grading of outflow obstruction.
    Khan Z; Mieza M; Bhola A; Starer P
    Urology; 1988 Jul; 32(1):72-7. PubMed ID: 2455375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement.
    Witjes WP; de Wildt MJ; Rosier PF; Caris CT; Debruyne FM; de la Rosette JJ
    J Urol; 1996 Sep; 156(3):1026-34. PubMed ID: 8709301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of uroflowmetry as a method of evaluating obstruction of the lower urinary tract].
    Minkov N; Kunchev S; Deliĭski P; Gotsev G
    Khirurgiia (Sofiia); 1983; 36(6):551-6. PubMed ID: 6199550
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study.
    de la Rosette JJ; Witjes WP; Schäfer W; Abrams P; Donovan JL; Peters TJ; Millard RJ; Frimodt-Møller C; Kalomiris P
    Neurourol Urodyn; 1998; 17(2):99-108. PubMed ID: 9514142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Objective evaluation of bladder outlet obstruction.
    Abrams P
    Br J Urol; 1995 Jul; 76 Suppl 1():11-5. PubMed ID: 7544210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.